Literature DB >> 4414795

Neuroblastoma, its natural history and prognosis: a study of 487 cases.

L M Wilson, G J Draper.   

Abstract

The natural history of neuroblastoma and factors affecting survival for this disease were studied in an unselected group of children notified to cancer registries in Britain during 1962-7. The three-year survival rate based on 487 cases was 23%; many of the cases were followed up for more than five years, and this made it possible to calculate long-term survival and recurrence rates. There were only five deaths among 110 cases followed for more than three years, 64 of the survivors having been followed for more than five years. Factors affecting the prognosis included age at diagnosis, site, histological grade at diagnosis, and the sex of the child. The interrelationship between these factors together with their effect on prognosis were analysed, and in particular we attempted to elucidate factors which might explain our observation that girls have a significantly better survival rate than boys. Direct histological evidence and also the analyses of survival and recurrence rates seem to support the suggestion that the likelihood of maturation for this tumour is greater for girls than for boys.

Entities:  

Mesh:

Year:  1974        PMID: 4414795      PMCID: PMC1611711          DOI: 10.1136/bmj.3.5926.301

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  13 in total

1.  IN SITU NEUROBLASTOMAS: A CONTRIBUTION TO THE NATURAL HISTORY OF NEURAL CREST TUMORS.

Authors:  J B BECKWITH; E V PERRIN
Journal:  Am J Pathol       Date:  1963-12       Impact factor: 4.307

2.  Neuroblastoma sympatheticum; a study and report of 217 cases.

Authors:  R E GROSS; S FARBER; L W MARTIN
Journal:  Pediatrics       Date:  1959-06       Impact factor: 7.124

3.  Maturation of sympathicoblastoma into ganglioneuroma; report of 2 patients with 20-and 46-year survivals respectively.

Authors:  F FOX; J DAVIDSON; L B THOMAS
Journal:  Cancer       Date:  1959 Jan-Feb       Impact factor: 6.860

4.  The Transformation of a Malignant Paravertebral Sympathicoblastoma into a Benign Ganglioneuroma.

Authors:  H Cushing; S B Wolbach
Journal:  Am J Pathol       Date:  1927-05       Impact factor: 4.307

5.  Special pattern of widespread neuroblastoma with a favourable prognosis.

Authors:  G J D'Angio; A E Evans; C E Koop
Journal:  Lancet       Date:  1971-05-22       Impact factor: 79.321

6.  Neuroblastoma: natural history and results of treating 133 cases.

Authors:  J Fortner; A Nicastri; M L Murphy
Journal:  Ann Surg       Date:  1968-01       Impact factor: 12.969

7.  Neuroblastoma in childhood.

Authors:  A A DeLorimier; K U Bragg; G Linden
Journal:  Am J Dis Child       Date:  1969-09

8.  A proposed staging for children with neuroblastoma. Children's cancer study group A.

Authors:  A E Evans; G J D'Angio; J Randolph
Journal:  Cancer       Date:  1971-02       Impact factor: 6.860

9.  Comparison of survival curves, 1956 versus 1962, in children with Wilms' tumor and neuroblastoma. Report of the Subcommittee on Childhood Solid Tumors, Solid Tumor Task Force, National Cancer Institute.

Authors:  W W Sutow; E A Gehan; R M Heyn; F H Kung; R W Miller; M L Murphy; D G Traggis
Journal:  Pediatrics       Date:  1970-05       Impact factor: 7.124

10.  Natural history and treatment of Wilms's tumour: an analysis of 335 cases occurring in England and Wales 1962-6.

Authors:  E M Ledlie; L S Mynors; G J Draper; P D Gorbach
Journal:  Br Med J       Date:  1970-10-24
View more
  28 in total

1.  Some aspects of epidemiology in paediatric oncology.

Authors:  L M Wilson
Journal:  Proc R Soc Med       Date:  1975-10

Review 2.  Micrometastases in neuroblastoma: are they clinically important?

Authors:  S A Burchill
Journal:  J Clin Pathol       Date:  2004-01       Impact factor: 3.411

3.  Guidelines for radioiodinated MIBG scintigraphy in children.

Authors:  Pierre Olivier; Paula Colarinha; Jure Fettich; Sibylle Fischer; Jörgen Frökier; Francesco Giammarile; Isky Gordon; Klaus Hahn; Levent Kabasakal; Mike Mann; Mercedes Mitjavila; Amy Piepsz; Ute Porn; Rune Sixt; Jeannette van Velzen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-26       Impact factor: 9.236

4.  Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma.

Authors:  S L Cohn; A W Rademaker; H R Salwen; W A Franklin; F Gonzales-Crussi; S T Rosen; K D Bauer
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

5.  Prognostic importance of DNA flow cytometrical, histopathological and immunohistochemical parameters in neuroblastomas.

Authors:  N L Carlsen; K Ornvold; I J Christensen; H Laursen; J K Larsen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

6.  Guidelines on nuclear medicine imaging in neuroblastoma.

Authors:  Zvi Bar-Sever; Lorenzo Biassoni; Barry Shulkin; Grace Kong; Michael S Hofman; Egesta Lopci; Irina Manea; Jacek Koziorowski; Rita Castellani; Ariane Boubaker; Bieke Lambert; Thomas Pfluger; Helen Nadel; Susan Sharp; Francesco Giammarile
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10       Impact factor: 9.236

7.  Primary small bowel ganglioneuroblastoma and Friedreich's ataxia.

Authors:  H Barr; R Page; W Taylor
Journal:  J R Soc Med       Date:  1986-10       Impact factor: 5.344

8.  Survivors of neuroblastoma and ganglioneuroma and their families.

Authors:  S Bundey; K Evans
Journal:  J Med Genet       Date:  1982-02       Impact factor: 6.318

9.  Chemotherapy of advanced neuroblastoma: does adriamycin contribute?

Authors:  J Ninane; J Pritchard; J S Malpas
Journal:  Arch Dis Child       Date:  1981-07       Impact factor: 3.791

10.  Stage II neuroblastoma. Adverse prognostic significance of lymph node involvement.

Authors:  J Ninane; J Pritchard; P H Morris Jones; J R Mann; J S Malpas
Journal:  Arch Dis Child       Date:  1982-06       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.